본문 바로가기

Evaluation of Target Specificity of Antibacterial Agents Using Staphylococcus aureus ddlA Mutants and D-Cycloserine in a Silkworm Infection Model

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY53(9) · pp.4025 · 2009
피인용
Web of Science 16
JCR IF
JCR 2008 4.716
ISSN
0066-4804

저자

  1. 쿠로가와 겐지제1저자교신저자National Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, South Korea
  2. Hamamoto, HiroshiLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
  3. Matsuo, MikiLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
  4. Nishida, SatoshiLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
  5. Yamane, NorikoDiscovery Research Laboratories, Shionogi and Co., Ltd., Japan
  6. 이복률National Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, South Korea
  7. Murakami, KazuhisaDiscovery Research Laboratories, Shionogi and Co., Ltd., Japan
  8. Maki, HidekiDiscovery Research Laboratories, Shionogi and Co., Ltd., Japan
  9. Sekimizu, KazuhisaLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan

초록

The availability of a silkworm larva infection model to evaluate the therapeutic effectiveness of antibiotics was examined. The 50% effective doses (ED50) of D-cycloserine against the Staphylococcus aureus ddlA mutant-mediated killing of larvae were remarkably lower than those against the parental strain-mediated killing of larvae. Changes in MICs and ED50 of other antibiotics were negligible, suggesting that these alterations are D-cycloserine selective. Therefore, this model is useful for selecting desired compounds based on their therapeutic effectiveness during antibiotic development.

식별자

WoS UID
000270014200060